Litramine
Dietary SupplementOther names: IQP G-002AS
NCT Number: NCT02488356
Safety and Efficacy of Litramine in weight loss.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: IQP G-002AS
Time frame: 12 weeks
InQpharm Group
Industry
Safety and Efficacy of Litramine IQP G-002AS for Weight Loss: A Randomised, Double-blind, Placebo-controlled, Parallel-group Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06576050
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT00687115
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT05715242
Behavior, Body Weight
Palo Alto, California, United States
View Trial DetailsNCT06978504
Body Weight, Body Weight Changes
Rio de Janeiro, Brazil
View Trial Details